Biotechnology movers and shakers on the move. Read new hires, promotions of executives, and more.
ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors
Biren Amin has been the chief financial officer (CFO) and chief strategy officer of Pyramid Biosciences, Inc. since August 2022. He also serves as a co-director on the board of trustees of Axiom REACH Foundation, a non-profit organization focused on addressing public health disparities.
BerGenBio Announces the Establishment of Oncology Scientific Advisory Board
"We are very proud and honored to have assembled a group of leading international NSCLC experts to guide us as we investigate bemcentinib in 1st line NSCLC STK11m in combination with today's standard of care," said Cristina Oliva, M.D., Chief Medical Officer of BerGenBio. "Their expertise will play an integral role in our evaluation of bemcentinib and its potential to provide significant benefits to patients who today face a particularly poor prognosis."
Nicole Hijnen Appointed President of the Board of Freya Pharma Solutions
In addition to bringing a wealth of experience from the healthtech industry at Philips, Dr. Nicole Hijnen has held a number of senior management and scientific positions worldwide. She obtained vast commercialization experience in the medical device industry and has a deep understanding of the EU and US markets.
Germo Gericke MD Appointed Chief Medical Officer of Ariceum Therapeutics
Germo Gericke MD brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International AG in Basel, Switzerland.
Leo Toole Appointed CFO of ViCentra
Leo Toole brings a wealth of experience in senior finance roles with more than 25 years’ experience in medical technology, pharmaceutical, and FMCG sectors.
NanoMosaic To Develop Novel Capture Methodologies as Dr Abhishek Chatterjee Joins NanoMosaic Scientific Advisory Board
Dr Abhishek Chatterjee is Professor of Chemistry at Boston College. Dr. Chatterjee's lab combines elements of chemical biology, synthetic biology and virology to develop new strategies for understanding and manipulating biological processes in mammalian cells